Former X CEO Yaccarino takes helm at GLP-1 focused telehealth firm eMed


FILE PHOTO: Linda Yaccarino, CEO of X Corp., attends the Milken Institute Global Conference 2025 in Beverly Hills, California, U.S., May 5, 2025. REUTERS/Mike Blake/File Photo

(Reuters) -Linda Yaccarino is taking the top job at eMed Population Health, a telehealth startup focused on GLP-1 weight loss drugs, nearly a month after stepping down as CEO of social media platform X.

Yaccarino, an advertising industry veteran, exited Elon Musk's X after two turbulent years during which she tried to revive its reputation among advertisers, who were wary of the platform's content as well as the billionaire's steady stream of controversial posts.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Tech News

Wingtech says it will 'exhaust all legal means' to restore Nexperia control
Humanoid startup Apptronik raises $520 million with backing from Google and Mercedes-Benz
Brazilian fintech Agibank raises $240 million in scaled-back US IPO
GlobalFoundries expects strong quarterly revenue on chips demand from data centers
T-Mobile boosts 2027 outlook on strong premium plan uptake
Shopify issues upbeat quarterly forecasts, $2 billion stock buyback plan
Activist investor Ancora to oppose Netflix-Warner Bros deal, backs Paramount bid
Dutch court orders investigation into Nexperia, upholds previous decisions including Chinese CEO suspension
Instagram's leader to testify in court on app design, youth mental health
Amazon Pharmacy to expand same-day delivery to about 4,500 US cities and towns

Others Also Read